Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for late-onset antidepressant-resistant depressive spectrum disorder in older adults
NL-OMON21203Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Infliximab with Placebo (2 arms). Primary endpoint: Depression severity at 8 weeks. Started Nov 2006; status: active, not recruiting.
02
Drugs
infliximab
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON21203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21203.